IndiaTickerGenpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Genpharmasec
BSE:GENPHARMA · ISIN INE861N01036
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Genpharmasec
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Genpharmasec Ltd - 531592 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March, 2026.BSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday, May 21, 2026.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St March, 2026.BSE · corporate action · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 21St May, 2026.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ABSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Outcome Of Separate Meeting Of Independent Directors Of The Company.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Unaudited Standalone & Consolidated Financial Result Of The Company For The Quarter Ended December 31, 2025.BSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Monday, February 09, 2026.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 31St December, 2025.BSE · corporate action · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 09Th February, 2026.
BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Submission Of Clear Copy Of Financial Results For The Quarter And Half Year Ended September 30, 2025.BSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September, 2025.BSE · corporate action · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday, November 06, 2025.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter & Half Year Ended 30Th September, 2025.BSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 06Th November, 2025.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Notice Of 33Rd Annual General Meeting Of The Company To Be Held On September 29, 2025.
BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Tuesday, 02Nd September, 2025.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Intimation Of Book Closure For Annual General MeetingBSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 02Nd September, 2025.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On Thursday, 07Th August, 2025.BSE · exchange filing · pdf
Source filing Genpharmasec Ltd - 531592 - Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2025.
BSE · financial results · pdf
Source filing Genpharmasec Ltd - 531592 - Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th June, 2025.BSE · corporate action · pdf
Source filing